GlobeNewswire Inc.··Telix Pharmaceuticals LimitedTelix's Brain Cancer Imaging Drug Advances in Europe After MAA Acceptance
Telix Pharmaceuticals' glioma imaging candidate TLX101-Px gains European regulatory validation, entering 210-day review phase with potential market approval expected.
TLXradiopharmaceuticalsPET imaging